Literature DB >> 18406835

Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.

.   

Abstract

Exogenous P supplementation is a common element of treatment regimens for infertility, particularly those relating to the assisted reproductive technologies.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18406835     DOI： 10.1016/j.fertnstert.2008.02.012

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  Potential influence of the microbiome on infertility and assisted reproductive technology.

Authors:  Ido Sirota; Shvetha M Zarek; James H Segars
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

2.  Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.

Authors:  Maryam N Shahin; Stephen T Magill; Cecilia L Dalle Ore; Jennifer A Viner; Pamela N Peters; David A Solomon; Michael W McDermott
Journal:  J Neurooncol       Date:  2019-03-13       Impact factor: 4.130

3.  Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support.

Authors:  Angeline N Beltsos; Mark D Sanchez; Kevin J Doody; Mark R Bush; Alice D Domar; Michael G Collins
Journal:  Reprod Health       Date:  2014-11-11       Impact factor: 3.223

4.  Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.

Authors:  Saghar Salehpour; Maryam Tamimi; Nasrin Saharkhiz
Journal:  Iran J Reprod Med       Date:  2013-11

5.  Luteal Phase Support in the Intrauterine Insemination (IUI) Cycles: A Randomized Double Blind, Placebo Controlled Study.

Authors:  Batool Hossein Rashidi; Fatemeh Davari Tanha; Haleh Rahmanpour; Mahya Ghazizadeh
Journal:  J Family Reprod Health       Date:  2014-12

6.  Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts.

Authors:  Daniel B Shapiro; Jennifer A Pappadakis; Nancy M Ellsworth; Howard I Hait; Zsolt Peter Nagy
Journal:  Hum Reprod       Date:  2014-05-20       Impact factor: 6.918

Review 7.  Recurrent pregnancy loss: current perspectives.

Authors:  Hady El Hachem; Vincent Crepaux; Pascale May-Panloup; Philippe Descamps; Guillaume Legendre; Pierre-Emmanuel Bouet
Journal:  Int J Womens Health       Date:  2017-05-17

8.  Luteal insufficiency in first trimester.

Authors:  Duru Shah; Nagadeepti Nagarajan
Journal:  Indian J Endocrinol Metab       Date:  2013-01

9.  The breast cancer epidemic: 10 facts.

Authors:  A Patrick Schneider; Christine M Zainer; Christopher Kevin Kubat; Nancy K Mullen; Amberly K Windisch
Journal:  Linacre Q       Date:  2014-08

10.  Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.

Authors:  Georg Griesinger; Christophe Blockeel; Gennady T Sukhikh; Ameet Patki; Bharati Dhorepatil; Dong-Zi Yang; Zi-Jiang Chen; Elke Kahler; Claire Pexman-Fieth; Herman Tournaye
Journal:  Hum Reprod       Date:  2018-12-01       Impact factor: 6.918
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.